Zelnic Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 0.24 M
as on 03-01-2025
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -54.30%
(FY 2021)
- Profit 61.69%
(FY 2021)
- Ebitda 57.02%
(FY 2021)
- Net Worth -38.75%
(FY 2021)
- Total Assets -80.35%
(FY 2021)
About Zelnic Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.24 M, as per Ministry of Corporate Affairs (MCA) records.
Navneet Kapoor and Parminder Kapoor serve as directors at the Company.
- CIN/LLPIN
U24304PB2017PTC046797
- Company No.
046797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2017
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Patiala, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Zelnic Biotech Private Limited offer?
Zelnic Biotech Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Antibiotic Tablets, Capsule & Syrup, Muscle Relaxant, Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Zelnic Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navneet Kapoor  | Director | 13-Nov-2019 | Current |
| Parminder Kapoor | Director | 13-Nov-2019 | Current |
Financial Performance of Zelnic Biotech.
Zelnic Biotech Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 54.3% decrease. The company also saw a substantial improvement in profitability, with a 61.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zelnic Biotech?
In 2021, Zelnic Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gnova Biotech Private LimitedActive 4 years 24 daysNavneet Kapoor and Parminder Kapoor are mutual person
Glenvox Biotech Private LimitedActive 5 years 2 monthsNavneet Kapoor and Parminder Kapoor are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zelnic Biotech?
Unlock and access historical data on people associated with Zelnic Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zelnic Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zelnic Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
